KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma

Jang Ho Cho; Bo Mi Ku; Jong Mu Sun; Se Hoon Lee; Jin Seok Ahn; Keunchil Park; Myung Ju Ahn

doi:10.1016/j.jtho.2017.10.014

KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma

Jang Ho Cho
, Bo Mi Ku
, Jong Mu Sun
, Se Hoon Lee
, Jin Seok Ahn
, Keunchil Park
, Myung Ju Ahn

Department of Internal Medicine

Samsung Medical Center, Sungkyunkwan university
Sungkyunkwan University

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Original language	English
Pages (from-to)	e29-e31
Journal	Journal of Thoracic Oncology
Volume	13
Issue number	3
DOIs	https://doi.org/10.1016/j.jtho.2017.10.014
State	Published - Mar 2018

Access to Document

10.1016/j.jtho.2017.10.014

Cite this

@article{e98d1392c5d540b0bb306bea4766db61,

title = "KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma",

author = "Cho, \{Jang Ho\} and Ku, \{Bo Mi\} and Sun, \{Jong Mu\} and Lee, \{Se Hoon\} and Ahn, \{Jin Seok\} and Keunchil Park and Ahn, \{Myung Ju\}",

year = "2018",

month = mar,

doi = "10.1016/j.jtho.2017.10.014",

language = "English",

volume = "13",

pages = "e29--e31",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma

AU - Cho, Jang Ho

AU - Ku, Bo Mi

AU - Sun, Jong Mu

AU - Lee, Se Hoon

AU - Ahn, Jin Seok

AU - Park, Keunchil

AU - Ahn, Myung Ju

PY - 2018/3

Y1 - 2018/3

UR - https://www.scopus.com/pages/publications/85037562749

U2 - 10.1016/j.jtho.2017.10.014

DO - 10.1016/j.jtho.2017.10.014

M3 - Article

C2 - 29102694

AN - SCOPUS:85037562749

SN - 1556-0864

VL - 13

SP - e29-e31

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 3

ER -

KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma

Access to Document

Other files and links

Cite this